BLPH - Bellerophon Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-5.711M

Cash

10.58M

Avg Qtr Burn

-2.754M

Short % of Float

1.84%

Insider Ownership

3.98%

Institutional Own.

45.08%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
INOpulse Details Interstitial lung disease, Pulmonary hypertension	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
INOpulse Details Chronic obstructive pulmonary disease, Pulmonary hypertension, Heart disease, Heart failure	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
INOpulse Details Sarcoidosis, Pulmonary hypertension	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
INOpulse® Details COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.